CEREVEL THERAPEUTICS HLDNG I (CERE)
Institutional ownership reported to the SEC as of Q3 2024, across 16 quarters.
2
Reporting holders
$20.7K
Reported value
0.0%
Held as options
-218
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| IFP Advisors, Inc | $15.5K | 346 | 0.00% | 3q | -54.7%-$18.8K |
| Blue Trust, Inc. | $5.2K | 126 | 0.00% | 4q | +5.9% |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2024 | 2 | $20.7K | 472 | 0 | 1 | 1 | 0.0% |
| Q2 2024 | 220 | $6.7B | 156,388,488 | 40 | 71 | 61 | 4.5% |
| Q1 2024 | 202 | $6.8B | 158,154,696 | 43 | 73 | 39 | 1.5% |
| Q4 2023 | 182 | $6.7B | 155,294,724 | 84 | 57 | 26 | 2.3% |
| Q3 2023 | 112 | $2.9B | 131,174,211 | 27 | 46 | 21 | 0.8% |
| Q2 2023 | 111 | $4.1B | 129,007,207 | 17 | 43 | 33 | 0.9% |
| Q1 2023 | 101 | $2.2B | 87,899,815 | 9 | 32 | 28 | 1.5% |
| Q4 2022 | 110 | $2.0B | 61,316,568 | 27 | 40 | 23 | 1.7% |
| Q3 2022 | 121 | $3.8B | 134,548,413 | 20 | 58 | 20 | 0.8% |
| Q2 2022 | 113 | $3.3B | 124,275,010 | 22 | 49 | 25 | 0.7% |
| Q1 2022 | 109 | $4.3B | 122,211,912 | 19 | 30 | 35 | 0.3% |
| Q4 2021 | 109 | $4.0B | 123,758,383 | 24 | 43 | 26 | 0.7% |
| Q3 2021 | 98 | $3.5B | 119,109,288 | 32 | 44 | 16 | 0.6% |
| Q2 2021 | 86 | $2.8B | 107,967,871 | 42 | 19 | 18 | 0.5% |
| Q1 2021 | 60 | $1.4B | 99,881,037 | 15 | 21 | 12 | 0.0% |
| Q4 2020 | 57 | $1.6B | 96,571,747 | 55 | 0 | 0 | 0.0% |